The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma.
 
Allison Betof Warner
No Relationships to Disclose
 
Alexander Noor Shoushtari
Consulting or Advisory Role - Castle Biosciences; Immunocore
Research Funding - Bristol-Myers Squibb; Immunocore; Xcovery
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Sean Houghton
Stock and Other Ownership Interests - Abbvie
Patents, Royalties, Other Intellectual Property - Merial melanoma vaccine for dogs (I)
 
Katherine Panageas
No Relationships to Disclose
 
Paul B. Chapman
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Takeda
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Adaptive Biotechnologies; Imvaq Therapeutics; Potenza Therapeutics; Serametrix; Tizona Therapeutics, Inc.; Trieza Therapeutics
Honoraria - Regeneron
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Ascentage Pharma; Beigene; Bristol-Myers Squibb; Chugai Pharma; FSC Pediatrics; Genentech; Lilly; MedImmune; Merck; Ono Pharmaceutical; Polaris; Polynoma; Potenza Therapeutics; Sellas Life Sciences; Tizona Therapeutics, Inc.
Research Funding - Bristol-Myers Squibb (Inst); F-Star Therapeutics; Genentech/Roche (Inst); Incyte (Inst); Leap Therapeutics (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for use of oncolytic Newcastle Disease virus.; I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bristol-Myers Squibb; Chugai Pharma; Janssen; Ono Pharmaceutical; Roche
 
Michael A. Postow
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Incyte; Merck; Newlink Genetics; Novartis
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Infinity Pharmaceuticals (Inst); Novartis (Inst); Rgenix; Rgenix